KLF2 and cancer: Since the transcription of miRNAs with anti-oncogenic activity is often regulated by TFs that are themselves oncosuppressors, we focused on EBF1, ETS2, and KLF2, which are frequently deregulated in cancer [37,38,39,40,41,42], and can bind to the EGFL7/miR-126 promoter regions.